Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring your adoptive cell therapy (ACT) meets safety regulations relating to VCN and RCL/RCR levels, even in lymphodepleted samples. By detecting the smallest changes in VCN, dPCR is our method of choice for pharmacokinetics (PK) assays. As for replication competent viruses, they can easily be detected using qPCR, ensuring patient safety and regulatory compliance.
